Correction to: Oral Administration of Bioactive Nanoparticulates for Inflammatory Bowel Disease Therapy by Mitigating Oxidative Stress and Restoring Intestinal Microbiota Homeostasis (Mol. Pharmaceutics (2024) 21:12 (6193−6205) DOI: 10.1021/acs.molpharmaceut.4c00499)

We hereby formally report an inadvertent error in Figure 4C that was identified postpublication. Specifically, a colonic HE-stained image in the SASP group was erroneously included, as it belongs to a separate experimental cohort unrelated to the SASP treatment. Our internal review confirms that this misassignment resulted from systematic nomenclature inconsistencies during image archiving, wherein files from distinct experimental groups were inadvertently cross-referenced. This constitutes an unintentional technical oversight with no bearing on the study’s scientific conclusions. While this error does not affect the study’s principal conclusions or compromise the overall data integrity, this correction is to ensure academic rigor and maintain the reproducibility standards of our research findings. (Figure presented).